NefiracetamBatch U3X35
COA-2026-3DEXJJ
Review the recorded results and original laboratory certificate for Nefiracetam.
Laboratory results
| Test | Result | Method | Status |
|---|---|---|---|
| Appearance | Good | See original report | Pass |
| Identity | Confirmed | HPLC | Pass |
| Measured contentSource label: Net peptide content | 104.37 mgReport only; no acceptance limit stated here. | HPLC | Report only |
| Heavy metals | Not detectedReference / specification: As, Cd, Cr, Hg, Pb | ICP-MS | Pass |
| Fentanyl screen | Not detected | Immunoassay, 50 ng/mL cutoff | Pass |
Values are shown as recorded. A report-only value is not a pass or fail; the original certificate is the source of record.
About this certificate
This certificate of analysis (COA) records batch / lot U3X35 for Nefiracetam, with laboratory testing recorded by ILS Laboratories on Nov 2, 2026. The published record includes appearance, identity, measured content, heavy metals, fentanyl screen. Recorded methods: HPLC; ICP-MS; Immunoassay, 50 ng/mL cutoff.
Sample & document details
- Sample / report title
- Nefiracetam - 100mg
- Certificate number
- COA-2026-3DEXJJ
- Labeled amount
- 100mg
- Method / testing panel
- Purity, Identity & Quantitation (HPLC), Heavy Metals (ICP-MS)
- Analysis date as recorded
- 11/02/2026
- Issue date as recorded
- 11/02/2026
Results apply to the submitted sample and the tests listed in its report. An omitted result is not evidence that a test was passed or performed.
Know what you’re reading.
Explore the tests listed on this report and how to read the laboratory’s findings.
Send the product name, label identifier and report number to our team.
For laboratory and research use only. A certificate of analysis is not medical advice, dosing guidance or evidence of safety or efficacy in humans.